Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
Motzer, Robert J, Dr, Hutson, Thomas E, DO, Glen, Hilary, MD, Michaelson, M Dror, MD, Molina, Ana, MD, Eisen, Timothy, Prof, Jassem, Jacek, Prof, Zolnierek, Jakub, MD, Maroto, Jose Pablo, MD, Mellado, Begoña, MD, Melichar, Bohuslav, Prof, Tomasek, Jiri, MD, Kremer, Alton, MD, Kim, Han-Joo, PhD, Wood, Karen, PhD, Dutcus, Corina, MD, Larkin, James, FRCP
Published in The lancet oncology (01.11.2015)
Published in The lancet oncology (01.11.2015)
Get full text
Journal Article
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
Choueiri, Toni K, Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N, Rini, Brian I, Donskov, Frede, Hammers, Hans, Hutson, Thomas E, Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J, Bjarnason, Georg A, Géczi, Lajos, Keam, Bhumsuk, Maroto, Pablo, Heng, Daniel Y.C, Schmidinger, Manuela, Kantoff, Philip W, Borgman-Hagey, Anne, Hessel, Colin, Scheffold, Christian, Schwab, Gisela M, Tannir, Nizar M, Motzer, Robert J
Published in The New England journal of medicine (05.11.2015)
Published in The New England journal of medicine (05.11.2015)
Get full text
Journal Article
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
Motzer, Robert J, Dr, Escudier, Bernard, MD, Tomczak, Piotr, MD, Hutson, Thomas E, DO, Michaelson, M Dror, MD, Negrier, Sylvie, Prof, Oudard, Stephane, Prof, Gore, Martin E, Prof, Tarazi, Jamal, MD, Hariharan, Subramanian, MD, Chen, Connie, PharmD, Rosbrook, Brad, MS, Kim, Sinil, MD, Rini, Brian I, MD
Published in The lancet oncology (01.05.2013)
Published in The lancet oncology (01.05.2013)
Get full text
Journal Article
Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
Hutson, Thomas E, Prof, Lesovoy, Vladimir, Prof, Al-Shukri, Salman, Prof, Stus, Viktor P, Prof, Lipatov, Oleg N, Prof, Bair, Angel H, PhD, Rosbrook, Brad, MS, Chen, Connie, PharmD, Kim, Sinil, MD, Vogelzang, Nicholas J, Prof
Published in The lancet oncology (01.12.2013)
Published in The lancet oncology (01.12.2013)
Get full text
Journal Article
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
Rini, Brian I, Dr, Escudier, Bernard, MD, Tomczak, Piotr, MD, Kaprin, Andrey, Prof, Szczylik, Cezary, MD, Hutson, Thomas E, DO, Michaelson, M Dror, MD, Gorbunova, Vera A, Prof, Gore, Martin E, Prof, Rusakov, Igor G, Prof, Negrier, Sylvie, Prof, Ou, Yen-Chuan, Prof, Castellano, Daniel, MD, Lim, Ho Yeong, Prof, Uemura, Hirotsugu, Prof, Tarazi, Jamal, MD, Cella, David, PhD, Chen, Connie, PharmD, Rosbrook, Brad, MS, Kim, Sinil, MD, Motzer, Robert J, MD
Published in The Lancet (British edition) (03.12.2011)
Published in The Lancet (British edition) (03.12.2011)
Get full text
Journal Article
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
MOTZER, Robert J, NOSOV, Dmitry, KOGAN, Mikhail, ALEKSEEV, Boris Y, STERNBERG, Cora N, SZCZYLIK, Cezary, CELLA, David, IVANESCU, Cristina, KRIVOSHIK, Andrew, STRAHS, Andrew, ESTEVES, Brooke, BERKENBLIT, Anna, EISEN, Timothy, HUTSON, Thomas E, BONDARENKO, Igor, LESOVOY, Vladimir, LIPATOV, Oleg, TOMCZAK, Piotr, LYULKO, Oleksiy, ALYASOVA, Anna, HARZA, Mihai
Published in Journal of clinical oncology (20.10.2013)
Published in Journal of clinical oncology (20.10.2013)
Get full text
Journal Article
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
Motzer, Robert J, Dr, Prof, Escudier, Bernard, MD, Oudard, Stéphane, Prof, Hutson, Thomas E, Prof, Porta, Camillo, MD, Bracarda, Sergio, MD, Grünwald, Viktor, Prof, Thompson, John A, Prof, Figlin, Robert A, Prof, Hollaender, Norbert, PhD, Urbanowitz, Gladys, BS, Berg, William J, MD, Kay, Andrea, MD, Lebwohl, David, MD, Ravaud, Alain, Prof
Published in The Lancet (British edition) (09.08.2008)
Published in The Lancet (British edition) (09.08.2008)
Get full text
Journal Article
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
ESCUDIER, Bernard, EISEN, Tim, DEMKOW, Tomasz, HUTSON, Thomas E, GORE, Martin, ANDERSON, Sibyl, HOFILENA, Gloria, MINGHUA SHAN, PENA, Carol, LATHIA, Chetan, BUKOWSKI, Ronald M, STADLER, Walter M, SZCZYLIK, Cezary, OUDARD, Stéphane, STAEHLER, Michael, NEGRIER, Sylvie, CHEVREAU, Christine, DESAI, Apurva A, ROLLAND, Frédéric
Published in Journal of clinical oncology (10.07.2009)
Published in Journal of clinical oncology (10.07.2009)
Get full text
Journal Article
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
MOTZER, Robert J, HUTSON, Thomas E, GARCIA-DEL-MURO, Xavier, SOSMAN, Jeffrey A, SOLSKA, Ewa, WILDING, George, THOMPSON, John A, KIM, Sindy T, CHEN, Isan, XIN HUANG, FIGLIN, Robert A, TOMCZAK, Piotr, MICHAELSON, M. Dror, BUKOWSKI, Ronald M, OUDARD, Stéphane, NEGRIER, Sylvie, SZCZYLIK, Cezary, PILI, Roberto, BJARNASON, Georg A
Published in Journal of clinical oncology (01.08.2009)
Published in Journal of clinical oncology (01.08.2009)
Get full text
Journal Article
Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma
ESCUDIER, Bernard, SZCZYLIK, Cezary, SHAH, Sonalee, BUKOWSKI, Ronald M, HUTSON, Thomas E, DEMKOW, Tomasz, STAEHLER, Michael, ROLLAND, Frédéric, NEGRIER, Sylvie, LAFERRIERE, Nicole, SCHEURING, Urban J, CELLA, David
Published in Journal of clinical oncology (10.03.2009)
Published in Journal of clinical oncology (10.03.2009)
Get full text
Journal Article
Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma
MOTZER, Robert J, HUTSON, Thomas E, BELLO, Akintunde, KORYTOWSKY, Beata, JINYU YUAN, VALOTA, Olga, MARTELL, Bridget, HARIHARAN, Subramanian, FIGLIN, Robert A, OLSEN, Mark R, HUDES, Gary R, BURKE, John M, EDENFIELD, William J, WILDING, George, AGARWAL, Neeraj, THOMPSON, John A, CELLA, David
Published in Journal of clinical oncology (20.04.2012)
Published in Journal of clinical oncology (20.04.2012)
Get full text
Journal Article
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
Tran, Hai T, PharmD, Liu, Yuan, PhD, Zurita, Amado J, MD, Lin, Ying, PhD, Baker-Neblett, Katherine L, MBA, Martin, Anne-Marie, PhD, Figlin, Robert A, MD, Hutson, Thomas E, DO, Sternberg, Cora N, MD, Amado, Rafael G, MD, Pandite, Lini N, MD, Heymach, John V, Dr
Published in The lancet oncology (01.08.2012)
Published in The lancet oncology (01.08.2012)
Get full text
Journal Article
Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
HUTSON, Thomas E, DAVIS, Ian D, PANDITE, Lini, FIGLIN, Robert A, MACHIELS, Jean-Pascal H, DE SOUZA, Paul L, ROTTEY, Sylvie, HONG, Bao-Fa, EPSTEIN, Richard J, BAKER, Katherine L, MCCANN, Lauren, CROFTS, Theresa
Published in Journal of clinical oncology (20.01.2010)
Published in Journal of clinical oncology (20.01.2010)
Get full text
Journal Article
Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma
RINI, Brian I, DROR MICHAELSON, M, KIM, Sindy T, CHEN, Isan, GEORGE, Daniel J, ROSENBERG, Jonathan E, BUKOWSKI, Ronald M, SOSMAN, Jeffrey A, STADLER, Walter M, HUTSON, Thomas E, MARGOLIN, Kim, HARMON, Charles S, DEPRIMO, Samuel E
Published in Journal of clinical oncology (01.08.2008)
Published in Journal of clinical oncology (01.08.2008)
Get full text
Journal Article
Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer
CHOUEIRI, Toni K, ROSS, Robert W, BUCKLE, Geoffrey C, KIM, William Y, PETRYLAK, Daniel P, RYAN, Christopher W, EISENBERGER, Mario A, MORTAZAVI, Amir, BUBLEY, Glenn J, TAPLIN, Mary-Ellen, ROSENBERG, Jonathan E, KANTOFF, Philip W, JACOBUS, Susanna, VAISHAMPAYAN, Ulka, YU, Evan Y, QUINN, David I, HAHN, Noah M, HUTSON, Thomas E, SONPAVDE, Guru, MORRISSEY, Stephanie C
Published in Journal of clinical oncology (10.02.2012)
Published in Journal of clinical oncology (10.02.2012)
Get full text
Journal Article
New treatment options for metastatic renal cell carcinoma
Rodriguez-Vida, Alejo, Hutson, Thomas E, Bellmunt, Joaquim, Strijbos, Michiel H
Published in ESMO open (2017)
Published in ESMO open (2017)
Get full text
Journal Article
Pazopanib Efficacy in Renal Cell Carcinoma: Evidence for Predictive Genetic Markers in Angiogenesis-Related and Exposure-Related Genes
XU, Chun-Fang, BING, Nan X, RAGONE, Leigh J, WHITTAKER, John C, SPRAGGS, Colin F, CARDON, Lon R, MOOSER, Vincent E, PANDITE, Lini N, BALL, Howard A, RAJAGOPALAN, Dilip, STERNBERG, Cora N, HUTSON, Thomas E, DE SOUZA, Paul, XUE, Zhengyu G, MCCANN, Lauren, KING, Karen S
Published in Journal of clinical oncology (20.06.2011)
Published in Journal of clinical oncology (20.06.2011)
Get full text
Journal Article